Hepatitis B virus (HBV)-transgenic mice exhibit competent innate immunity and are therefore an ideal model for considering intrinsic or cell-based mechanisms in HBV pathophysiology. A highly replicative model that has been little used, let alone characterized, is the Tg1.4HBV-s-rec strain derived from cross breeding of HBV-transgenic mouse models that either accumulate (Alb/HBs, Tg[Alb1-HBV]Bri44) or lack (Tg1.4HBV-s-mut) the
hepatitis B surface antigen (
HBsAg). Tg1.4HBV-s-rec hepatocytes secreted
HBsAg,
Hepatitis B extracellular
antigen (
HBeAg) and produced HBV virions. Transmission electron microscopy visualised viral particles (Tg1.4HBV-s-rec), nuclear capsid formations (Tg1.4HBV-s-mut and Tg1.4HBV-s-rec) and endoplasmic reticulum malformations (Alb/HBs). Viral replication in Tg1.4HBV-s-rec and Tg1.4HBV-s-mut differed in
HBsAg expression and interestingly in the distribution of HBV core
antigen (
HBcAg) and HBV ×
protein. While in Tg1.4HBV-s-mut hepatocytes, the
HBcAg was located in the cytoplasm, in Tg1.4HBV-s-rec hepatocytes, the
HBcAg appeared in the nuclei, suggesting a more productive replication. Finally, Tg1.4HBV-s-rec mice showed symptoms of mild
hepatitis, with reduced liver function and elevated serum
transaminases, which appeared to be related to natural killer T cell activation. In conclusion, the study of Alb/HBs, Tg1.4HBV-s-mut and their F1 progeny provides a powerful tool to elucidate HBV pathophysiology, especially in the early
HBeAg-positive phases of
chronic infection and
chronic hepatitis.